Prosecution Insights
Last updated: October 25, 2026

Edwards Lifesciences Innovation (Israel) Ltd.

Technology area: Medical Devices & Mechanical Engineering

9 pending office actions • 3 art units • 8 examiners • 0 of 9 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Analysis

Edwards Lifesciences Innovation (Israel) Ltd. has 8 pending office actions in the Medical Devices & Mechanical Engineering technology area. These matters are assigned to 7 distinct examiners, showing that most examiners are handling a single case for the company. This distribution requires the applicant to navigate the specific tendencies of 7 different individuals across their active portfolio. The variety of examiners suggests that the company's prosecution experience is broad and not tied to a single individual's preferences across the 8 total actions.

The pending actions are located within 3 distinct art units, suggesting that the technical focus is relatively narrow despite the number of examiners involved. RIOS, GABRIELLA GISELLE BONO is the busiest examiner for this entity, with 2 pending office actions under their review. Because this examiner holds 2 of the pending actions, their specific prosecution history and allowance rates may have a more pronounced impact on the portfolio's overall progress than other examiners. Practitioners should prioritize understanding the tendencies of this busiest examiner while maintaining flexible strategies for the other 3 art units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

9
Total Pending OAs
3
Non-Final OAs
6
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
3
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (44%)
4
Medium (44%)
1
Easy (11%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only4 (44%)
§112 only1 (11%)
Multi-statute (no §101)4 (44%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
9
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RIOS, GABRIELLA GISELLE BONO 2 15.4% +0.0%
LE, KHOA TAN 1 75.4% +41.7%
FLORES, ADRIAN 1 100.0% +0.0%
SHAH, NILAY J 1 76.3% +46.9%
PATEL, AREN 1 77.6% +17.2%
NORTH, ISABELLA SARAH HYO SO 1 63.6% +15.0%
WOLF, MEGAN YARNALL 1 61.0% +39.1%
WILLSE, DAVID H 1 67.3% +14.0%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18622096 PROTECTION OF CORONARY BLOOD VESSELS DURING CARDIAC PROCEDURES FLORES, ADRIAN —

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18352924 INTERCOMMISSURAL LEAFLET SUPPORT RIOS, GABRIELLA GISELLE BONO 4d overdue
18354872 FASTENERS FOR PERCUTANEOUS DEVICES RIOS, GABRIELLA GISELLE BONO 16d
18472162 TISSUE-CONTRACTING IMPLANTS PATEL, AREN 26d
18491737 CATHETER STABILIZATION DEVICES SHAH, NILAY J —
17990570 STEERABLE CATHETER NORTH, ISABELLA SARAH HYO SO —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18472162 TISSUE-CONTRACTING IMPLANTS PATEL, AREN 26d
17843495 IMPLANT-ADHERING TECHNIQUES WOLF, MEGAN YARNALL 26d
18981509 TISSUE ANCHOR HANDLING SYSTEMS AND METHODS LE, KHOA TAN —
18491737 CATHETER STABILIZATION DEVICES SHAH, NILAY J —
17990570 STEERABLE CATHETER NORTH, ISABELLA SARAH HYO SO —
17385749 LEAFLET-RESTRAINING TECHNIQUES WILLSE, DAVID H —

Top Art Units

Art UnitApps
3774 6
3783 2
3771 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18981509 TISSUE ANCHOR HANDLING SYSTEMS AND METHODS LE, KHOA TAN 3771 §103 Final Rejection — Pending Dec 14, 2024
18622096 PROTECTION OF CORONARY BLOOD VESSELS DURING CARDIAC PROCEDURES FLORES, ADRIAN 3774 §103 Non-Final OA — Pending Mar 29, 2024
18491737 CATHETER STABILIZATION DEVICES SHAH, NILAY J 3783 §102§112 Final Rejection — Pending Oct 20, 2023
18472162 TISSUE-CONTRACTING IMPLANTS PATEL, AREN 3774 §102§103 Final Rejection 26d Pending Sep 21, 2023
18354872 FASTENERS FOR PERCUTANEOUS DEVICES RIOS, GABRIELLA GISELLE BONO 3774 §103 Final Rejection 16d Pending Jul 19, 2023
18352924 INTERCOMMISSURAL LEAFLET SUPPORT RIOS, GABRIELLA GISELLE BONO 3774 §102§103§112 Final Rejection 4d overdue Pending Jul 14, 2023
17990570 STEERABLE CATHETER NORTH, ISABELLA SARAH HYO SO 3783 §103§112 Non-Final OA — Pending Nov 18, 2022
17843495 IMPLANT-ADHERING TECHNIQUES WOLF, MEGAN YARNALL 3774 §112 Final Rejection 26d Pending Jun 17, 2022
17385749 LEAFLET-RESTRAINING TECHNIQUES WILLSE, DAVID H 3774 §103 Non-Final OA — Pending Jul 26, 2021

Managing Edwards Lifesciences Innovation (Israel) Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Edwards Lifesciences Innovation (Israel) Ltd. have?

Edwards Lifesciences Innovation (Israel) Ltd. has 9 pending office actions as of October 2026, spread across 3 art units and 8 examiners.

Which USPTO examiner handles the most Edwards Lifesciences Innovation (Israel) Ltd. applications?

Gabriella Giselle Bono Rios has the most, with 2 of Edwards Lifesciences Innovation (Israel) Ltd.'s pending office actions.

What technology area are Edwards Lifesciences Innovation (Israel) Ltd.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month